Disposition of cosalane, a novel anti-HIV agent, in isolated perfused rat livers

Drug Metabolism and Disposition

Volumn 27, Issue 8, 1999, Pages 947-950

  Udata, Chandrasekhar ^a   Mitra, Ashim K ^a   Badr, Mostafa Z ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIVIRUS AGENT; COSALANE; CYTOCHROME P450; DIGITONIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG DISPOSITION; DRUG METABOLISM; DRUG PENETRATION; DRUG UPTAKE; HUMAN IMMUNODEFICIENCY VIRUS; LIPID BILAYER; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VIRUS ENVELOPE; VIRUS REPLICATION;

ANIMALS; ANTI-HIV AGENTS; AURINTRICARBOXYLIC ACID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ENZYME INDUCTION; L-LACTATE DEHYDROGENASE; LIVER; MALE; PROTEIN BINDING; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032770434     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Belinsky SA, Badr MZ, Kauffman, FC and Thurman RG (1986) Mechanism of hepatotoxicity in periportal regions of the liver lobule due to allyl alcohol: Studies on thiol and energy status. J Pharmacol Exp Ther 238:1132-1137.
2. Bigelow J, Mathews L, Chrin L, Horton P and McCormack J (1994) Analytical studies and murine pharmacokinetics of cosalane. Proc Am Assoc Cancer Res 35:427.
3. Boon MR and Zammit VA (1988) Use of selectively permeabilized isolated rat hepatocyte preparation to study changes in the properties of overt camitine palmitoyltransferase activity in situ. Biochem J 249:645-652.
4. Cushman M, Golebiewski WM, McMohan JB, Buckheit RW Jr, Clanton DJ, Weislow O, Haugwitz RD, Bader JP, Graham L and Rice WG (1994) Design, synthesis and biological evaluation of cosalane, a novel anti-HIV agent which inhibits multiple features of virus reproduction. J Med Chem 37:3040-3050.
5. Cushman M, Golebiewski WM, Pommier Y, Mazumder A, Reymen D, De Clercq E, Graham L and Rice WG (1995) Cosalane analogues with enhanced potencies as inhibitors of HIV-1 protease integrase. J Med Chem 38:443-452.
6. Fiskum G, Craig SW, Decker GL and Lehninger AL (1980) The cytoskeleton of digitonin-treated rat hepatocytes. Proc Natl Acad Sci USA 77:3430-3434.
7. Fiskum G and Lehninger AL (1980) The mechanisms and regulation of mitochondrial Ca2+ transport. Fed Proc 39:2432-2436.
8. Golebiewski WM, Bader JP and Cushman M (1993) Design and synthesis of cosalane, a novel anti-HIV agent. Bioorg Med Chem Lett 3:1739-1742.
9. Golebiewski WM, Keyes RF and Cushman M (1996) Exploration of the effects of linker chain modifications on anti-HIV activities in a series of cosalane analogues. Bioorg Med Chem 4:1637-1648.
10. Keyes RF, Golebiewski WM and Cushman M (1996) Correlation of anti-HIV potency with lipophilicity in a series of cosalane analogs having normal alkenyl and phosphodiester chains as cholestane replacements. J Med Chem 39:508-514.
11. Rowland M and Tozer TN (1989) Movement through membranes, in Clinical Pharmacokinetics (Rowland M and Tozer TN, eds) pp 103-112, Lea & Febiger, Philadelphia.
12. Udata C, Kuchimanchi KR, Pal D, Johnston TP and Mitra AK (1998) Biliary excretion and tissue distribution of cosalane, a highly lipophilic and novel anti-HIV agent in rats (Abstract). Pharm Sci 1:S679 .
13. Venkatesh S, Li J, Xu Y, Vishnuvajjala R and Anderson BD (1996) Intrinsic solubility estimation and pH-solubility behavior of cosalane (NSC 658586), an extremely hydrophobic diprotic acid. Pharm Res 13:1453-1459.
14. Wils P, Warnery A, Phung-ba V, Legrain S and Scherman D (1994) High lipophilicity decreases drug transport across intestinal epithelial cells. J Pharmacol Exp Ther 269:654-658.
15. Wolkoff AW, Johansen KL and Goeser T (1987) The isolated perfused rat liver: Preparation and application. Anal Biochem 167:1-14.